Official Title
Olfactory Retraining Therapy and Budesonide Nasal Rinse for Anosmia Treatment in Patients Post-CoVID 19. A Randomized Controlled Trial
Brief Summary

The study will be a randomized controlled trial, involving patients with hyposmia/anosmia of onset immediately after an upper respiratory viral illness, assigned to three distinct study arms. Nasal irrigations will be prescribed to all three groups (BID). In addition, one arm will receive a paper hand-out about post-viral anosmia with instructions to smell common household items (current care) and act as a control group. The second group will receive an essential oil retraining kit, whereas the third group will receive the same olfactory training kit and a prescription to use budesonide with the nasal irrigations. Olfactory scores will be tested at the enrollment, 3 months and at 6 months.

Withdrawn
Olfactory Disorder

Other: Olfactory retraining

Olfactory retraining Olfactory training is performed by exposing patients twice daily to essential oils with four specific odors, present in glass jars with soaked cotton pads: phenyl ethyl alcohol, rose; eucalyptol, eucalyptus; citronellal, lemon; eugenol, cloves.
Other Name: Array

Drug: corticosteroid nasal irrigation

Nasal irrigation with corticosteroid (budesonide) consists of 240-mL nasal irrigation with Pulmicort Respules (0.5mg) across both nose sides via NeilMed Sinus Rinse bottle (Santa Rosa, California, USA).
Other Name: Budesonide nasal irrigation

Other: smell household Items

Participants will receive a paper hand-out about post-viral anosmia with instructions to smell common household items

Other: Nasal Irrigation

Participants from all three groups will use nasal rinse (NeilMed Sinus Rinse) two times a day.
Other Name: Nasal Rinse

Eligibility Criteria

Inclusion Criteria:

- Adults 18 years of age or older

- Hyposmia/anosmia of onset immediately after an upper respiratory viral illness
confirmed on Snap n' Sniff threshold testing,

- Capable, in the opinion of the primary investigator, of providing informed consent to
participate in the study. Participants are required to sign an informed consent form
indicating they understand the purpose and nature of the study, and that they are
willing to participate.

Exclusion Criteria:

- active cigarette smoker

- chronic rhinosinusitis

- head trauma with loss of consciousness

- inability to read/understand English

- previous hyposmia/anosmia complaint

- pregnancy

- previous sinus

- skull base or brain surgery

- current participation in another clinical trial at the time of initial visit

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Canada
Locations

St. Joseph's Health Care
London, Ontario, Canada

Leigh Sowerby, MD, FRCSC, Principal Investigator
Western University

Lawson Health Research Institute
NCT Number
Keywords
anosmia
hyposmia
COVID19
post-viral anosmia
snap and sniff olfactory test
budesonide
MeSH Terms
COVID-19
Anosmia
Budesonide